Shopping Cart
- Remove All
- Your shopping cart is currently empty
Narlaprevir (SCH 900518) is an orally active, selective, and potent hepatitis C virus nonstructural protein 3 (HCV NS3) inhibitor, with antiviral activity against HCV and inhibition of SARS-CoV-2, used for studying viral infections.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
2 mg | $458 | In Stock | |
25 mg | Inquiry | 10-14 weeks |
Description | Narlaprevir (SCH 900518) is an orally active, selective, and potent hepatitis C virus nonstructural protein 3 (HCV NS3) inhibitor, with antiviral activity against HCV and inhibition of SARS-CoV-2, used for studying viral infections. |
Targets&IC50 | Ketoamide:7 nM (Ki), NS3 protease:40 nM (EC90), NS3 protease:6 nM (Ki), Replicon RNA:40 nM (EC90) |
In vitro | Narlaprevir is a selective NS3 protease inhibitor with a Ki of 6 nM and an EC90 of 40 nM. Narlaprevir is also an inhibitor of SARS-CoV 3CLpro with an IC50 of 2.3 μM. [1] [2] |
In vivo | Narlaprevir rats, when administered orally, showed a very good AUC of 6.5 μM·h and a bioavailability of 46%. It is well distributed in target organs. The liver concentration of rats was 750 ng/g at 8 hours (C8h) after administration. [1] |
Alias | SCH900518, SCH 900518 |
Molecular Weight | 707.96 |
Formula | C36H61N5O7S |
Cas No. | 865466-24-6 |
Smiles | C(N[C@H](C(C(NC1CC1)=O)=O)CCCC)(=O)[C@@H]2[C@@]3([C@@](C3(C)C)(CN2C([C@@H](NC(NC4(CS(C(C)(C)C)(=O)=O)CCCCC4)=O)[C@](C)(C)C)=O)[H])[H] |
Relative Density. | 1.21 g/cm3 |
Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | ||||||||||||||||||||||||||||||
Solubility Information | H2O: < 1 mg/mL (insoluble) DMSO: 40 mg/mL (56.5 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.